News & Updates
Filter by Specialty:
Empagliflozin lowers mortality, cardiorenal events even in COPD presence
Among patients with type 2 diabetes mellitus and cardiovascular disease, those with concomitant chronic obstructive pulmonary disease (COPD) are at higher risk of mortality and adverse cardiorenal outcomes, including heart failure, according to post hoc analyses of the EMPA-REG OUTCOME trial. However, these outcomes can be prevented with empagliflozin treatment, regardless of the presence of COPD.
Empagliflozin lowers mortality, cardiorenal events even in COPD presence
28 Mar 2022
Moderate intake of dietary isoflavone lowers lung cancer risk in nonsmoking women
A moderate increase in the consumption of foods rich in isoflavone can help reduce the risk of lung cancer in women with no smoking history, suggests a study.
Moderate intake of dietary isoflavone lowers lung cancer risk in nonsmoking women
26 Mar 2022
Sotrovimab reduces hospitalization, death in patients with COVID-19 regardless of serostatus
Treatment with sotrovimab reduces the risk of all-cause hospitalization or death in patients with COVID-19 who are at high risk of progression to severe disease, regardless of anti-SARS-CoV-2 serostatus, according to a study presented at CROI 2022.
Sotrovimab reduces hospitalization, death in patients with COVID-19 regardless of serostatus
23 Mar 2022
Omicron more stable than ancestral strain on surfaces, resistant to neutralizing mAbs
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more stable than the ancestral strain on various smooth and porous surfaces and demonstrates marked resistance to neutralizing monoclonal antibodies (mAbs), researchers from the University of Hong Kong (HKU) have reported.
